ABBV AbbVie Earnings and EPS analysis

EPS in 2026 (TTM): $2.03

Last Report Period Date: Mar 31, 2026

As of June this year, based on AbbVie's most recent financial report, the company's trailing twelve months EPS is $2.03. During 2025, ABBV reported a per-share earnings of $2.37, which shows a decline compared to the EPS of $2.4 recorded in 2024. AbbVie's EPS for the quarterly period ending on Mar 31, 2026 came in at $0.39.

The yearly earnings per share during 2025 was $2.37, a decline of 1.3% compared to $2.4 recorded in 2024. Over the quarter ending Mar 31, 2026, the earnings per share came in at $0.39, reflecting a 45.8% decline compared to the same quarter a year earlier. As of March 2026, the TTM EPS is $2.03. During 2024, the annual earnings per share was $2.4, representing a decrease of 12.1% compared to 2023.

AbbVie has recorded a decline in earnings per share of 45.8% in the past 12 months (YoY, quarterly). During the past three years, ABBV registered an average yearly EPS growth of -29.1%. AbbVie had an average annual EPS growth of -2.8% in the last five years. Over the last decade, ABBV had an average annual earnings per share growth of -2.8%.